<DOC>
	<DOC>NCT00477581</DOC>
	<brief_summary>This purpose of this study is to compare the effect of exenatide to that of sitagliptin on 2-hour postprandial glucose in subjects with type 2 diabetes mellitus.</brief_summary>
	<brief_title>A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Treatment with metformin for at least 2 months Has HbA1c 7.0% to 11.0%, inclusive, at screening Body mass index (BMI)25 kg/m^2 to 45 kg/m^2, inclusive List of medications that are not allowed or the patient has been on stable treatment for at least 2 months: Hormone replacement therapy (female subjects) Oral contraceptives (female subjects) Antihypertensive agents Lipidlowering agents Thyroid replacement therapy Exclusion Criteria Has been treated with exenatide (BYETTA速) or any DPP4 inhibitor prior to screening Received any study medication or participated in any type of clinical trial within 30 days prior to screening Has donated blood within 60 days of screening visit or is planning to donate blood during the study Treated with any of the following medications: Sulfonylurea or Thiazolidinedione within 3 months of screening; Alphaglucosidase inhibitor, meglitinide, nateglinide, or pramlintide (SYMLIN速)within 30 days of screening; Insulin within 2 weeks prior to screening or insulin for longer than 1 week within 6 months of screening; Drugs that directly affect gastrointestinal motility, including but not limited to, anticholinergics, macrolide antibiotics, dopamine antagonists, opioids, and Reglan速(metoclopramide); Systemic corticosteroids by oral, intravenous, or intramuscular route; or potent, inhaled, or intrapulmonary (including ADVAIR速) steroids known to have a high rate of systemic absorption;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>diabetes</keyword>
	<keyword>exenatide</keyword>
	<keyword>sitagliptin</keyword>
	<keyword>Amylin</keyword>
	<keyword>Lilly</keyword>
</DOC>